Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 18, 2021, titled "press release dated September 18, 2021 titled Zydus Cadila receives final approval from USFDA for Vortioxetine Tablets"".
Press Release Sep 18 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 09 2021
- Press Release Sep 06 2021
- Press Release Aug 23 2021
- Press Release Aug 20 2021
- Press Release Aug 17 2021
Later from Zydus Lifesciences
- Press Release Sep 24 2021
- Press Release Oct 08 2021
- Press Release Oct 22 2021
- Press Release Nov 08 2021
- Press Release Nov 10 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences